Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
Cancer Investigation · 09.08.2026 · 44 (7) · 707-717
DOI: 10.1080/07357907.2026.2672004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Investigation, online erschienen am 15.05.2026. Verfasst von Ja Yoon Heo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Docetaxel, Tumor Suppressor Protein p53, Prostatic Neoplasms, Castration-Resistant, Retinoblastoma Binding Proteins. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Yonsei University College of Medicine Graduate School Research Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Urology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Förderung
- Yonsei University College of Medicine Graduate School Research Fund
Zitieren
APA
Heo, J. Y., Lee, C., Shin, H., Cho, S., Beom, S. H., Choi, Y. D., Han, W. K., Ham, W. S., Jang, W. S., Han, H., Lee, J., Heo, J. E., Khalaf, D., Emmenegger, U., Kim, S., Kim, C. G., Jung, M., & Shin, S. J. (2026). Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel. Cancer Investigation, 44(7), 707-717. https://doi.org/10.1080/07357907.2026.2672004
Vancouver
Heo JY, Lee C, Shin H, Cho S, Beom SH, Choi YD, et al. Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel. Cancer Investigation. 2026;44(7):707-717. doi:10.1080/07357907.2026.2672004
BibTeX
@article{Heo2026,
author = {Heo, Ja Yoon and Lee, Chung and Shin, Heesun and Cho, Sungmin and Beom, Seung Hoon and Choi, Young-Deuk and Han, Woong Kyu and Ham, Won Sik and Jang, Won Sik and Han, Hyunho and Lee, Jongsoo and Heo, Ji Eun and Khalaf, Daniel and Emmenegger, Urban and Kim, Sangwoo and Kim, Chang Gon and Jung, Minsun and Shin, Sang Joon},
title = {Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel},
journal = {Cancer Investigation},
year = {2026},
volume = {44},
number = {7},
pages = {707--717},
doi = {10.1080/07357907.2026.2672004}
}
EUVIMED